Superiority of the ROMA index over HE4 and CA125 for diagnosing ovarian cancer in a Bangladeshi cohort.

Das PK, Hossain S, Rahman AFMA, Saha P, Ahmed S, Mustakim TM, Tanjim KF, Chowdhury AK, Jishan TR, Tabassum T

Open source

DOI
10.1016/j.clinsp.2026.100927
Published
2026 Apr 8
Container
Clinics (Sao Paulo, Brazil)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clinsp.2026.100927,
  title = {Superiority of the ROMA index over HE4 and CA125 for diagnosing ovarian cancer in a Bangladeshi cohort.},
  author = {Das PK and Hossain S and Rahman AFMA and Saha P and Ahmed S and Mustakim TM and Tanjim KF and Chowdhury AK and Jishan TR and Tabassum T},
  year = {2026},
  journal = {Clinics (Sao Paulo, Brazil)},
  doi = {10.1016/j.clinsp.2026.100927},
  url = {https://doi.org/10.1016/j.clinsp.2026.100927}
}

RIS

TY  - JOUR
TI  - Superiority of the ROMA index over HE4 and CA125 for diagnosing ovarian cancer in a Bangladeshi cohort.
AU  - Das PK
AU  - Hossain S
AU  - Rahman AFMA
AU  - Saha P
AU  - Ahmed S
AU  - Mustakim TM
AU  - Tanjim KF
AU  - Chowdhury AK
AU  - Jishan TR
AU  - Tabassum T
PY  - 2026
JO  - Clinics (Sao Paulo, Brazil)
DO  - 10.1016/j.clinsp.2026.100927
UR  - https://doi.org/10.1016/j.clinsp.2026.100927
ER  - 

APA

PK, D., S, H., AFMA, R., P, S., S, A., TM, M., KF, T., AK, C., TR, J., & T, T. (2026). Superiority of the ROMA index over HE4 and CA125 for diagnosing ovarian cancer in a Bangladeshi cohort.. Clinics (Sao Paulo, Brazil). https://doi.org/10.1016/j.clinsp.2026.100927

Source records